DePuy Synthes Received FDA Approval for TELIGEN™ System
On October 20, 2022, DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, provides one of the most comprehensive orthopedics portfolios in the world that helps heal and restore movement for the millions of patients, announced that it has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for TELIGEN™ System. The system is an integrated technology platform that enables minimally invasive surgical transforaminal lumbar interbody fusion (MIS-TLIF) procedures through digital tools for visualization and access.
The TELIGEN™ System is comprised ...
